Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence of solid cancer in patients with follicular lymphoma.
Sorigue M, Prusila REI, Jauhiainen J, Mercadal S, Postila A, Salmi P, Tanhua T, Tikkanen S, Kakko S, Kuitunen H, Pollari M, Nystrand I, Kuusisto MEL, Vasala K, Jantunen E, Korkeila E, Karihtala P, Sancho JM, Turpeenniemi-Hujanen T, Kuittinen O. Sorigue M, et al. Among authors: kuusisto mel. Acta Oncol. 2019 Nov;58(11):1564-1569. doi: 10.1080/0284186X.2019.1643918. Epub 2019 Aug 1. Acta Oncol. 2019. PMID: 31368395
Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.
Lemma SA, Kuusisto M, Haapasaari KM, Sormunen R, Lehtinen T, Klaavuniemi T, Eray M, Jantunen E, Soini Y, Vasala K, Böhm J, Salokorpi N, Koivunen P, Karihtala P, Vuoristo J, Turpeenniemi-Hujanen T, Kuittinen O. Lemma SA, et al. Carcinogenesis. 2017 Aug 1;38(8):812-820. doi: 10.1093/carcin/bgx061. Carcinogenesis. 2017. PMID: 28854563 Free PMC article.
Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era.
Prusila REI, Sorigue M, Jauhiainen J, Mercadal S, Postila A, Salmi P, Tanhua T, Tikkanen S, Kakko S, Kuitunen H, Pollari M, Nystrand I, Kuusisto MEL, Vasala K, Jantunen E, Korkeila E, Karihtala P, Sancho JM, Turpeenniemi-Hujanen T, Kuittinen O. Prusila REI, et al. Among authors: kuusisto mel. Br J Haematol. 2019 Nov;187(3):364-371. doi: 10.1111/bjh.16090. Epub 2019 Jul 3. Br J Haematol. 2019. PMID: 31267514 Free article.
Twist and Zeb1 expression identify mycosis fungoides patients with low risk of disease progression.
Häyrinen MJ, Uotila PM, Sahi H, Haapasaari KM, Teppo HR, Soini Y, Lapela M, Vasala K, Turpeenniemi-Hujanen T, Ranki A, Kuusisto MEL, Kuittinen O. Häyrinen MJ, et al. Among authors: kuusisto mel. J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e95-e98. doi: 10.1111/jdv.16009. Epub 2019 Nov 12. J Eur Acad Dermatol Venereol. 2020. PMID: 31596985 No abstract available.
Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma.
Kuitunen H, Kaprio E, Karihtala P, Makkonen V, Kauppila S, Haapasaari KM, Kuusisto M, Jantunen E, Turpeenniemi-Hujanen T, Kuittinen O. Kuitunen H, et al. Ann Hematol. 2020 Aug;99(8):1823-1831. doi: 10.1007/s00277-020-04140-0. Epub 2020 Jun 23. Ann Hematol. 2020. PMID: 32577843 Free PMC article. Clinical Trial.
Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation.
Chan MC, Savela J, Ollikainen RK, Teppo HR, Miinalainen I, Pirinen R, Kari EJM, Kuitunen H, Turpeenniemi-Hujanen T, Kuittinen O, Kuusisto MEL. Chan MC, et al. Among authors: kuusisto mel. Oxid Med Cell Longev. 2021 Feb 1;2021:8026941. doi: 10.1155/2021/8026941. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33603952 Free PMC article.
24 results